SEARCH

SEARCH BY CITATION

References

  • 1
    Fernandez-Llama P, Gines P, Schrier RW. Pathogenesis of sodium retention in cirrhosis. The arterial vasodilatation hypothesis of ascites formation. In: ArroyoV, GinesP, RodesJ, SchrierRW, eds. Ascites and Renal Dysfunction in Liver Disease. 2nd ed. Malden, MA: Blackwell Science, 2005: 201214.
  • 2
    Agre P, Kozono D. Aquaporin water channels: molecular mechanisms for human diseases. FEBS Lett 2003; 555: 7278.
  • 3
    Nielsen S, Chou CL, Marples D, Christensen EI, Kishore BK, Knepper MA. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci U S A 1995; 92: 10131017.
  • 4
    Asahina Y, Izumi N, Enomoto N, Sasaki S, Fushimi K, Marumo F, et al. Increased gene expression of water channel in cirrhotic rat kidneys. HEPATOLOGY 1995; 21(1): 169173.
  • 5
    Fernandez-Llama P, Jimenez W, Bosch-Marce M, Arroyo V, Nielsen S, Knepper MA. Dysregulation of renal aquaporins and Na-Cl cotransporter in CCl4-induced cirrhosis. Kidney Int 2000; 58(1): 216228.
  • 6
    Fernandez-Llama P, Turner R, Dibona G, Knepper MA. Renal expression of aquaporins in liver cirrhosis induced by chronic common bile duct ligation in rats. J Am Soc Nephrol 1999; 10: 19501957.
  • 7
    Jonassen TE, Brond L, Torp M, Graebe M, Nielsen S, Skott O, et al. Effects of renal denervation on tubular sodium handling in rats with CBL-induced liver cirrhosis. Am J Physiol Renal Physiol 2003; 284: F555F563.
  • 8
    Ivarsen P, Frokiaer J, Aagaard NK, Hansen EF, Bendtsen F, Nielsen S, et al. Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis. Gut 2003; 52: 11941199.
  • 9
    Pedersen RS, Bentzen H, Bech JN, Nyvad O, Pedersen EB. Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load. Kidney Int 2003; 63: 14171425.
  • 10
    Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. HEPATOLOGY 1996; 23(1): 164176.
  • 11
    Valenti G, Laera A, Pace G, Aceto G, Lospalluti ML, Penza R, et al. Urinary aquaporin 2 and calciuria correlate with the severity of enuresis in children. J Am Soc Nephrol 2000; 11: 18731881.
  • 12
    Ishikawa S. Urinary excretion of aquaporin-2 in pathological states of water metabolism. Ann Med 2000; 32(2): 9093.
  • 13
    Kanno K, Sasaki S, Hirata Y, Ishikawa S, Fushimi K, Nakanishi S, et al. Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med 1995; 332: 15401545.
  • 14
    Wen H, Frokiaer J, Kwon TH, Nielsen S. Urinary excretion of aquaporin-2 in rat is mediated by a vasopressin-dependent apical pathway. J Am Soc Nephrol 1999; 10: 14161429.
  • 15
    Saito T, Ishikawa SE, Sasaki S, Nakamura T, Rokkaku K, Kawakami A, et al. Urinary excretion of aquaporin-2 in the diagnosis of central diabetes insipidus. J Clin Endocrinol Metab 1997; 82: 18231827.
  • 16
    Saito T, Ishikawa SE, Ando F, Okada N, Nakamura T, Kusaka I, et al. Exaggerated urinary excretion of aquaporin-2 in the pathological state of impaired water excretion dependent upon arginine vasopressin. J Clin Endocrinol Metab 1998; 83: 40344040.
  • 17
    DiGiovanni SR, Nielsen S, Christensen EI, Knepper MA. Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat. Proc Natl Acad Sci U S A 1994; 91: 89848988.
  • 18
    Rai T, Sekine K, Kanno K, Hata K, Miura M, Mizushima A, et al. Urinary excretion of aquaporin-2 water channel protein in human and rat. J Am Soc Nephrol 1997; 8: 13571362.
  • 19
    Funayama H, Nakamura T, Saito T, Yoshimura A, Saito M, Kawakami M, et al. Urinary excretion of aquaporin-2 water channel exaggerated dependent upon vasopressin in congestive heart failure. Kidney Int 2004; 66: 13871392.
  • 20
    Gines P, Berl T, Bernardi M, Bichet DG, Hamon G, Jimenez W, et al. Hyponatremia in cirrhosis: from pathogenesis to treatment. HEPATOLOGY 1998; 28: 851864.
  • 21
    Gines P, Cardenas A, Schrier RW. Liver disease and the kidney. In: SchrierRW, ed. Diseases of the Kidney and Urinary Tract. 8th ed. Philadelphia, PA: Lippincott, Williams & Wilkins, 2006.
  • 22
    Ishikawa SE, Schrier RW. Pathogenesis of hyponatremia: the role of arginine-vasopressin. In: ArroyoV, GinesP, RodesJ, SchrierRW, eds. Ascites and Renal Dysfunction in Liver Disease. 2nd ed. Malden, MA: Blackwell Science, 2005: 315328.
  • 23
    Leaf A, Bartter FC, Santos RF, Wrong O. Evidence in man that urinary electrolyte loss induced by pitressin is a function of water retention. J Clin Invest 1953; 32: 868878.
  • 24
    Verbalis JG. Whole-body volume regulation and escape from antidiuresis. Am J Med 2006; 119(7 Suppl 1 ): S21S29.
  • 25
    Fernandez-Llama P, Ecelbarger CA, Ware JA, Andrews P, Lee AJ, Turner R, et al. Cyclooxygenase inhibitors increase Na-K-2Cl cotransporter abundance in thick ascending limb of Henle's loop. Am J Physiol 1999; 277(2 Pt 2): F219F226.
  • 26
    Kim GH, Lee JW, Oh YK, Chang HR, Joo KW, Na KY, et al. Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel. J Am Soc Nephrol 2004; 15: 28362843.
  • 27
    Starklint J, Bech JN, Pedersen EB. Urinary excretion of aquaporin-2 after furosemide and felodipine in healthy humans. Scand J Clin Lab Invest 2005; 65: 249261.
  • 28
    Zhou H, Yuen PS, Pisitkun T, Gonzales PA, Yasuda H, Dear JW, et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int 2006; 69: 14711476.
  • 29
    King LS, Choi M, Fernandez PC, Cartron JP, Agre P. Defective urinary-concentrating ability due to a complete deficiency of aquaporin-1. N Engl J Med 2001; 345: 175179.
  • 30
    Lopez-Novoa JM, Rengel MA. A micropuncture study of salt and water retention in chronic experimental cirrhosis. Am J Physiol 1977; 232: F315F318.
  • 31
    Bank N, Aynedjian HS. A micropuncture study of renal salt and water retention in chronic bile duct obstruction. J Clin Invest 1975; 55: 9941002.
  • 32
    Gerbes AL, Gulberg V, Gines P, Decaux G, Gross P, Gandjini H, et al. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology 2003; 124: 933939.
  • 33
    Wong F, Blei AT, Blendis LM, Thuluvath PJ. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. HEPATOLOGY 2003; 37: 182191.